The Peer Review Process: Past, Present, and Future
Br J Biomed Sci 81:12054 (2024)
Going circular: history, present, and future of circRNAs in cancer
Oncogene 42: 2783-2800 (2023)
Epigenetic Regulation of Alternative Splicing: how lncRNAs Tailor the Message
Noncoding RNA 7:21 (2021)
Investigating ROS, RNS, and H2S-Sensitive Signaling Proteins
Methods Mol Biol 1990:27-42 (2019)
Working with Hypoxia
Methods Mol Biol 1990:109-133 (2019)
The d16HER2 splice variant: a friend or foe of HER2-positive cancers?
Cancers (Basel) 11: E902. (2019)
Alternative splicing in the Hippo pathway – implications for disease and potential therapeutic targets
Genes 13: pii: E161 (2018)
Oligonucleotide-based systems: DNA, microRNAs, DNA/RNA aptamers
Essays in Biochemistry 60, 27-35 (2016)
The oncogene ERG: a key factor in prostate cancer
Oncogene 35, 403-414 (2016)
Detection of thiol modifications by hydrogen sulphide
Methods in Enzymology 555, 233-251 (2015)
The evolutionarily conserved multifunctional glycine-rich RNA binding proteins play key roles in development and stress adaptation
Physiologia Plantarum 153, 1-11 (2014)
Alternative splicing: role in cancer development and progression
Int J Cell Biol 2013:421606 (2013)
Aberrant alternative splicing is another hallmark of cancer
Int J Cell Biol, 2013:463786 (2013)
The relationship between the structure and biological actions of green tea catechins
Food Chemistry 141, 3282-3289 (2013)
SRPK1 inhibition in vivo: modulation of VEGF splicing and potential treatment for multiple diseases
Biochem. Soc. Trans. 40, 831-835 (2012)
Role of splice variants in the metastatic progression of prostate cancer
Biochem. Soc. Trans. 40, 870-874 (2012)
MicroRNAs: their discovery, biogenesis, function and potential use as biomarkers in non-invasive prenatal diagnostics
Int. J. Mol. Epidemiol. Gen. 2, 253-260 (2011)
A Report of the First International WT1 Meeting, University of Manchester UK, 2008
Int. J. Mol. Epidemiol. Gen. 1: 76-82 (2010)
RAP55: insights into an evolutionarily conserved protein family
Int. J. Biochem. Cell. Biol. 41: 977-981 (2009)
New insights into the function of the Wilms tumor suppressor gene WT1 in podocytes
Am. J. Physiol. Renal Physiol. 295: F12-7 (2008)
Targeting splicing in prostate cancer
International Journal of Molecular Sciences, accepted (2018)
The post-transcriptional roles of WT1, a multifunctional zinc-finger protein
BBA - Reviews on Cancer 1785: 55-62 (2008)
Alternative splicing in angiogenesis: the vascular endothelial growth factor paradigm
Cancer Lett. 249: 133-142 (2007)
Murine Denys-Drash syndrome: evidence of podocyte de-differentiation and systemic mediation of glomerulosclerosis
Hum. Mol. Genet. 12: 2379-2394 (2003)
Multiple roles for the Wilms’ tumor suppressor, WT1
Cancer Res. 59:1747s-1751s (1999)
Multifunctional proteins suggest connections between transcriptional and post-transcriptional processes
Bioessays 19: 903-909 (1997)
Transcription and masking of mRNA in germ cells: involvement of Y-box proteins
Chromosoma 104: 469-478 (1996)
Masking of mRNA by Y-box proteins
FASEB J. 10: 435-443 (1996)
A role for Y-box proteins in cell proliferation
Bioessays 17: 9-11 (1995)
Plants and pathogens: in concert or in conflict?
Ormond Papers 7: 135-145 (1990)